China FDA to start spot inspections of drug and medical device makers

China will begin regular surprise inspections on pharmaceutical and medical device firms from September 1, according to the China Food and Drug Administration (CFDA) reported by the state news agency Xinhau.

A surprise check will be initiated without early notice to the companies and law enforcement will disclose no information about the process and problems spotted during the inspection, according to the CFDA. When all the evidence has been collected and the nature of problems determined, local CFDA units will inform the manufacturers of rectification instructions.

Surprise checks will also be launched when authorities are contacted by whistle-blowers from the public or become suspicious of certain firms, said the CFDA.